Osaic Holdings
SEEL

Osaic Holdings’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Osaic Holdings’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-64
Closed -$4.76K – 7671
2024
Q1 		$4.76K Sell
64
-4
-6% -$528 ﹤0.01% 6112
2023
Q4 		$12.1K Sell
68
-100
-60% -$49.2K ﹤0.01% 5741
2023
Q3 		$118K Buy
168
+165
+5,500% +$707K ﹤0.01% 4378
2023
Q2 		$12.4K Hold
3
– – ﹤0.01% 5854
2023
Q1 		$7.2K Sell
3
-2
-40% -$5.86K ﹤0.01% 6163
2022
Q4 		$13K Hold
5
– – ﹤0.01% 5826
2022
Q3 		$20K Hold
5
– – ﹤0.01% 5596
2022
Q2 		$13K Hold
5
– – ﹤0.01% 5929
2022
Q1 		$16K Sell
5
-2
-29% -$8.6K ﹤0.01% 5855
2021
Q4 		$42K Hold
7
– – ﹤0.01% 5270
2021
Q3 		$62K Buy
7
+1
+17% +$8.59K ﹤0.01% 4946
2021
Q2 		$56K Buy
6
+4
+200% +$65.7K ﹤0.01% 4964
2021
Q1 		$35K Sell
2
-1
-33% -$11.7K ﹤0.01% 5131
2020
Q4 		$18K Hold
3
– – ﹤0.01% 5233
2020
Q3 		$11K Buy
3
+2
+200% +$7.18K ﹤0.01% 5236
2020
Q2 		$3K Hold
1
– – ﹤0.01% 5712
2020
Q1 		$1K Buy
+1
New +$3.72K ﹤0.01% 5956

Other funds holding SEEL

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CHA
Carmichael Hill & Associates Gaithersburg, Maryland $282M AUM 32.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings's SEEL Position: Q2 2024 in Review

Osaic Holdings sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q2 2024, closing a stake of 64 shares — an estimated $4.76K sold.

Osaic Holdings first reported a position in SEEL in Q1 2020 and held it in 17 quarters. The position peaked at $118K in Q3 2023. 18 funds tracked by Wall St. Rank hold SEEL as of Q2 2024.

  • Osaic Holdings reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Osaic Holdings sold 64 Seelos Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $4.76K.
  • Osaic Holdings first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2020 and held it in 17 quarters.
  • Osaic Holdings's Seelos Therapeutics, Inc. Common Stock position peaked at $118K in Q3 2023.
  • 18 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Osaic Holdings's 13F filing for Q2 2024, filed 13 Aug 2024.